{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T06:08:03Z","timestamp":1776492483761,"version":"3.51.2"},"reference-count":54,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4175,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1111\/j.1600-6143.2011.03554.x","type":"journal-article","created":{"date-parts":[[2011,6,10]],"date-time":"2011-06-10T13:18:34Z","timestamp":1307711914000},"page":"1359-1367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":145,"title":["Targeting B Cells and Antibody in Transplantation"],"prefix":"10.1016","volume":"11","author":[{"given":"M.R.","family":"Clatworthy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2011.03554.x_bib1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/nri2729","article-title":"Effector and regulatory B cells: Modulators of CD4(+) T cell immunity","volume":"10","author":"Lund","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib2","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.4049\/jimmunol.177.11.7715","article-title":"B cell-mediated antigen presentation is required for the pathogenesis of acute cardiac allograft rejection","volume":"177","author":"Noorchashm","year":"2006","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib3","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1111\/j.1600-6143.2010.03223.x","article-title":"B cells help alloreactive T cells differentiate into memory T cells","volume":"10","author":"Ng","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-065X.2010.00937.x","article-title":"T cells and follicular dendritic cells in germinal center B-cell formation and selection","volume":"237","author":"Vinuesa","year":"2010","journal-title":"Immunol Rev"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib5","doi-asserted-by":"crossref","first-page":"14723","DOI":"10.1073\/pnas.0507223102","article-title":"Lymphoid neogenesis in chronic rejection: Evidence for a local humoral alloimmune response. Proc","volume":"102","author":"Thaunat","year":"2005","journal-title":"Natl Acad Sci U S A"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/01.ASN.0000113316.52371.2E","article-title":"Lymphatic neoangiogenesis in human kidney transplants is associated with immunologically active lymphocytic infiltrates","volume":"15","author":"Kerjaschki","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/TP.0b013e3181d3f271","article-title":"B cells and plasma cells in coronaries of chronically rejected cardiac transplants","volume":"89","author":"Wehner","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/ni1330","article-title":"Lymphoid organ development: From ontogeny to neogenesis","volume":"7","author":"Drayton","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib9","doi-asserted-by":"crossref","first-page":"15517","DOI":"10.1073\/pnas.0807841105","article-title":"BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact. Proc","volume":"105","author":"Scholz","year":"2008","journal-title":"Natl Acad Sci U S A"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.trre.2010.05.004","article-title":"B-lymphocyte homeostasis and BLyS-directed immunotherapy in transplantation","volume":"24","author":"Parsons","year":"2010","journal-title":"Transplant Rev"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nri2762","article-title":"FcgammaRIIB in autoimmunity and infection: Evolutionary and therapeutic implications","volume":"10","author":"Smith","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: The neonatal Fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e3181a9e89a","article-title":"Intravenous immunoglobulin a natural regulator of immunity and inflammation","volume":"88","author":"Jordan","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/nbt1143","article-title":"Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels","volume":"23","author":"Vaccaro","year":"2005","journal-title":"Nat Biotechnol"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","article-title":"CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients","volume":"32","author":"Blair","year":"2010","journal-title":"Immunity"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","article-title":"Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells","volume":"117","author":"Iwata","year":"2011","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1749-6632.2009.05137.x","article-title":"B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer","volume":"1183","author":"DiLillo","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/ki.2010.162","article-title":"Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype","volume":"78","author":"Pallier","year":"2010","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib19","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1172\/JCI39933","article-title":"Identification of a B cell signature associated with renal transplant tolerance in humans","volume":"120","author":"Newell","year":"2010","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1600-6143.2010.03027.x","article-title":"An unexpected counter-regulatory role of IL-10 in B-lymphocyte-mediated transplantation tolerance","volume":"10","author":"Zhao","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrneph.2010.111","article-title":"B cells and transplantation tolerance","volume":"6","author":"Kirk","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib22","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1002\/art.27524","article-title":"Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: results of a randomized, double-blind, placebo-controlled, phase I\/II study","volume":"62","author":"Ostergaard","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nrrheum.2009.184","article-title":"CD19: A promising B cell target for rheumatoid arthritis","volume":"5","author":"Tedder","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib24","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.4049\/jimmunol.1002983","article-title":"B lymphocytes differentially influence acute and chronic allograft rejection in mice","volume":"186","author":"Dilillo","year":"2011","journal-title":"J Immunol"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.trre.2010.01.004","article-title":"The yin and yang of B cells in graft rejection and tolerance","volume":"24","author":"Zarkhin","year":"2010","journal-title":"Transplant Rev"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib26","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/TP.0b013e3181a6bac5","article-title":"Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection","volume":"87","author":"Fehr","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib27","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/TP.0b013e3181d21e7f","article-title":"Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation","volume":"89","author":"Vo","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib28","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/TP.0b013e3181da1cc3","article-title":"Combined posttransplant prophylactic IVIg\/anti-CD 20\/plasmapheresis in kidney recipients with preformed donor-specific antibodies: A pilot study","volume":"89","author":"Loupy","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib29","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1600-6143.2007.01737.x","article-title":"Acute cellular rejection with CD20-positive lymphoid clusters in kidney transplant patients following lymphocyte depletion","volume":"7","author":"Kayler","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib30","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1097\/TP.0b013e3181a235fd","article-title":"A randomized, doubleblind, placebo-controlled, study of single-dose rituximab as induction in renal transplantation","volume":"87","author":"Tyden","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib31","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMc0808481","article-title":"B-cell-depleting induction therapy and acute cellular rejection","volume":"360","author":"Clatworthy","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1346-8138.2009.00639.x","article-title":"Rituximab-induced vasculitis: A case report and review of the medical published work","volume":"36","author":"Kim","year":"2009","journal-title":"J Dermatol"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib33","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nm1673","article-title":"B lymphocyte-directed immunotherapy promotes long-term islet allograft survival in nonhuman primates","volume":"13","author":"Liu","year":"2007","journal-title":"Nat Med"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib34","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/ar1942","article-title":"Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus","volume":"8","author":"Dorner","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib35","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/BOR.0b013e32833b475e","article-title":"Biologics in the treatment of systemic lupus erythematosus","volume":"22","author":"Lateef","year":"2010","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib36","doi-asserted-by":"crossref","unstructured":"Zand MS, Vo T, Huggins J et al. Polyclonal rabbit antithymocyte globulin triggers B-cell and plasma cell apoptosis by multiple pathways. Transplantation 2005; 79: 1507\u20131515.","DOI":"10.1097\/01.TP.0000164159.20075.16"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib37","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1600-6143.2010.03093.x","article-title":"Efficacy of induction therapy with ATG and intravenous immunoglobulins in patients with low-level donor-specific HLA-antibodies","volume":"10","author":"Bachler","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib38","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/MOT.0b013e328330f304","article-title":"Proteasome inhibition for antibody-mediated rejection","volume":"14","author":"Everly","year":"2009","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib39","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1097\/TP.0b013e3181d9e1c0","article-title":"Effect of the proteasome inhibitor bortezomib on humoral immunity in two presensitized renal transplant candidates","volume":"89","author":"Wahrmann","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib40","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1600-6143.2009.02968.x","article-title":"Bortezomib as the sole post-renal transplantation desensitization agent does not decrease donor-specific anti-HLA antibodies","volume":"10","author":"Sberro-Soussan","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/TP.0b013e3181dde912","article-title":"Clonal deletion with bortezomib followed by low or no maintenance immunosuppression in renal allograft recipients","volume":"90","author":"Trivedi","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib42","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/TP.0b013e3181c6ff8d","article-title":"Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection","volume":"89","author":"Walsh","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib43","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/TP.0b013e3181fdd9b0","article-title":"The role of proteasome inhibition with bortezomib in the treatment of antibody-mediated rejection after kidney-only or kidney-combined organ transplantation","volume":"90","author":"Flechner","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib44","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ki.2010.15","article-title":"Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejection","volume":"77","author":"Ashton-Chess","year":"2010","journal-title":"Kidney Int"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib45","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1093\/ndt\/gfq230","article-title":"Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat","volume":"25","author":"Vogelbacher","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib46","first-page":"1483","article-title":"Protective immunity remains intact after antibody removal by means of proteasome inhibition","volume":"90","author":"Everly","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib47","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1182\/blood-2007-11-125526","article-title":"CD32B is highly expressed on clonal plasma cells from patients with systemic light-chain amyloidosis and provides a target for monoclonal antibody-based therapy","volume":"111","author":"Zhou","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib48","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/ni1440","article-title":"FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis.","volume":"8","author":"Xiang","year":"2007","journal-title":"Nat Immunol"},{"issue":"Suppl 1","key":"10.1111\/j.1600-6143.2011.03554.x_bib49","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.tmrv.2009.09.010","article-title":"The use of immunoglobulin therapy for patients undergoing solid organ transplantation: An evidence-based practice guideline","volume":"24","author":"Shehata","year":"2010","journal-title":"Transfus Med Rev"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib50","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","article-title":"Anti-inflammatory actions of intravenous immunoglobulin","volume":"26","author":"Nimmerjahn","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib51","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1097\/TP.0b013e3181dd6bf1","article-title":"Intravenous immunoglobulins promote skin allograft acceptance by triggering functional activation of CD4+Foxp3+ T cells","volume":"89","author":"Tha-In","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib52","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-6143.2008.02451.x","article-title":"The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection","volume":"9","author":"Locke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2011.03554.x_bib53","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1111\/j.1600-6143.2010.03191.x","article-title":"Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access","volume":"10","author":"Lonze","year":"2010","journal-title":"Am J Transplant"},{"issue":"suppl 2","key":"10.1111\/j.1600-6143.2011.03554.x_bib54","first-page":"241","article-title":"Prevention of acute humoral rejection with C5 inhibition. [2009 ATC abstract 178]","volume":"9","author":"Stegall","year":"2009","journal-title":"Am J Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2011.03554.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522279982?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522279982?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2011.03554.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:54:12Z","timestamp":1761627252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522279982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":54,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1600613522279982"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03554.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting B Cells and Antibody in Transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2011.03554.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}